59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
Saved in:
| Title: | 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121). |
|---|---|
| Authors: | Knox, J.1 (AUTHOR), McNamara, M.G.2 (AUTHOR), Goyal, L.3 (AUTHOR), Cosgrove, D.4 (AUTHOR), Springfeld, C.5 (AUTHOR), Sjoquist, K.6 (AUTHOR), Park, J.O.7 (AUTHOR), Verdaguer, H.8 (AUTHOR), Braconi, C.9 (AUTHOR), Ross, P.10 (AUTHOR), Oh, D-Y.11 (AUTHOR), De Gramont, A.12 (AUTHOR), Shroff, R.T.13 (AUTHOR), Zalcberg, J.R.14 (AUTHOR), Palmer, D.15 (AUTHOR), Valle, J.W.2 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS381-S381. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.338 |
